These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of Max binding protein as a novel binding protein of Nck1 and characterization of its role in inhibiting human liver cancer SK-HEP-1 cells. Zhou Q; Huang T; Wang YF; Zhang KS; Chen D; Peng BG Chin Med J (Engl); 2012 Sep; 125(18):3336-9. PubMed ID: 22964333 [TBL] [Abstract][Full Text] [Related]
5. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells. Smith AG; Popov N; Imreh M; Axelson H; Henriksson M J Cell Biochem; 2004 Aug; 92(6):1282-95. PubMed ID: 15258910 [TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6. Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802 [TBL] [Abstract][Full Text] [Related]
7. Chromatin dynamics at the hTERT promoter during transcriptional activation and repression by c-Myc and Mnt in Xenopus leavis oocytes. Wahlström T; Belikov S; Arsenian Henriksson M Exp Cell Res; 2013 Dec; 319(20):3160-9. PubMed ID: 23860446 [TBL] [Abstract][Full Text] [Related]
8. Proteomic discovery of Max as a novel interacting partner of C/EBPalpha: a Myc/Max/Mad link. Zada AA; Pulikkan JA; Bararia D; Geletu M; Trivedi AK; Balkhi MY; Hiddemann WD; Tenen DG; Behre HM; Behre G Leukemia; 2006 Dec; 20(12):2137-46. PubMed ID: 17082780 [TBL] [Abstract][Full Text] [Related]
9. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6. Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544 [TBL] [Abstract][Full Text] [Related]
10. Nano-LC based proteomic approach identifies that E6AP interacts with ENO1 and targets it for degradation in breast cancer cells. Mishra M; Sharma A; Thacker G; Trivedi AK IUBMB Life; 2019 Dec; 71(12):1896-1905. PubMed ID: 31329371 [TBL] [Abstract][Full Text] [Related]
11. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Tomaić V; Pim D; Banks L Virology; 2009 Oct; 393(1):7-10. PubMed ID: 19700180 [TBL] [Abstract][Full Text] [Related]
12. Mnt transcriptional repressor is functionally regulated during cell cycle progression. Popov N; Wahlström T; Hurlin PJ; Henriksson M Oncogene; 2005 Dec; 24(56):8326-37. PubMed ID: 16103876 [TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of miR-210 decreases hypoxic glioma stem cells stemness and radioresistance. Yang W; Wei J; Guo T; Shen Y; Liu F Exp Cell Res; 2014 Aug; 326(1):22-35. PubMed ID: 24930954 [TBL] [Abstract][Full Text] [Related]
17. Comparative proteomics analysis on differentiation of human promyelocytic leukemia HL-60 cells into granulocyte and monocyte lineages. Wang WJ; Tang W; Qiu ZY Ai Zheng; 2009 Feb; 28(2):117-21. PubMed ID: 19550115 [TBL] [Abstract][Full Text] [Related]